Position in RZLT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$160,332
-$25,485,828 QoQ
Shares Held
52,568
-98.1% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RZLT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. RZLT ranks #263 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,099,318 | $363,731,344 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
317,058 | $141,579,078 | |
| 3 | INCY |
Incyte Corp
|
1,253,138 | $117,945,347 | |
| 4 | RPRX |
Royalty Pharma plc
|
2,120,692 | $101,729,594 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
3,761,437 | $81,247,039 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
628,075 | $66,199,104 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
2,246,943 | $62,240,320 | |
| 8 | COGT |
Cogent Biosciences, Inc.
|
1,600,168 | $61,590,466 |
All Filings in RZLT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $160,332 | 52,568 | Shares | Other | 2026-05-15 | |
| 2025-09-30 | $25,646,160 | 2,728,315 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $12,873,704 | 2,886,481 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $5,351,215 | 1,845,247 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $4,131,404 | 843,144 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $5,473,481 | 1,128,553 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $4,503,088 | 1,047,230 | Shares | Other | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||